Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists find ’stem cells’ in human breast cancer

25.02.2003


Discovery could explain current treatment failures and lead to more effective therapies for many cancers



Of all the neoplastic cells in human breast cancers, only a small minority – perhaps as few as one in 100 – appear to be capable of forming new malignant tumors, according to just-published research by scientists in the University of Michigan Comprehensive Cancer Center. The discovery could help researchers zero in on the most dangerous cancer cells to develop new, more effective treatments.

"These tumor-inducing cells have many of the properties of stem cells," says Michael Clarke, M.D., a U-M professor of internal medicine, who directed the study. "They make copies of themselves – a process called self-renewal – and produce all the other kinds of cells in the original tumor."


Although similar cells have been identified in human leukemia, these are the first to be found in solid tumors, Clarke adds. The cells were isolated from primary or metastatic breast cancers removed from nine women treated for cancer at the U-M’s Cancer Center.

The discovery – reported this week in the online early edition of the Proceedings of the National Academy of Sciences – also may explain why current treatments for metastatic breast cancer often fail, says Max S. Wicha, M.D., an oncologist and director of the U-M Comprehensive Cancer Center.

"The goal of all our existing therapies has been to kill as many cells within the tumor as possible," Wicha says. "This study suggests that the current model may not be getting us anywhere, because we have been targeting the wrong cells with the wrong treatments. Instead, we need to develop drugs targeted at the tumor’s stem cells. If we are to have any real cures in advanced breast cancer, it will be absolutely necessary to eliminate these cells.

"What this means for women with cancer is that, for the first time, we can define what we believe are the important cells – the cells which determine whether the cancer will come back or be cured," Wicha adds. "Before this, we didn’t even know there were such cells."

All cancer cells have a unique pattern of proteins, similar to a fingerprint, on their surface membranes, explains Muhammad Al-Hajj, Ph.D., a U-M post-doctoral fellow and first author of the PNAS paper. " We used specific antibodies and flow cytometry technology to segregate the phenotypically heterogenous cancer cells within a tumor into isolated populations based on their surface protein markers," Al-Hajj says.

These isolated cell populations were then individually injected into immune-deficient mice and the mice were examined for tumor growth every week for up to six months.

Al-Hajj found a small group of cells, with a phenotype common to all but one of the human tumors in the study, could form new cancers in mice. These cells all expressed a protein marker called CD44, in addition to having either very low levels or no levels of a marker called CD24.

"As few as 100 to 200 of these tumor-inducing cells, isolated from eight of nine tumors in the study, easily formed tumors in mice, while tens of thousands of the other cancer cells from the original tumor failed to do so," Clarke says.

The fact that tumor-inducing stem cells from eight of nine women showed a common surface marker pattern is significant, Wicha explains. "Even though it’s only nine patients, it shows that the markers identifying these stem cells were expressed in the majority of breast cancer patients in the study. This may not be the only expression pattern on every patient’s stem cells, but it demonstrates the validity of the cancer stem cell model."

To test the stem cell’s ability to regenerate the original tumor, U-M scientists repeated the experiment up to four times. First, 200 cells with the unique two-marker surface pattern were isolated from the original human tumor. When these cells produced a breast tumor in a mouse, Al-Hajj removed the mouse tumor and used flow cytometry to isolate 200 stem cells from it. These cells were then injected into another mouse to produce another tumor. Once again, the tumor was harvested, stem cells were separated, and injected into another mouse. Each procedure is called a passage.

"Tumor cells with this particular surface marker pattern produced a new tumor in the next generation of mouse every time," Clarke explains. "When we examined the tumors after each passage, we found their cell diversity to be the same as the original tumor."

Given that tumor-inducing cells now have been identified in breast and blood cancers, Wicha and Clarke believe it is likely that similar cells drive the development of other types of cancer, as well. The U-M Comprehensive Cancer Center is establishing a new research program to identify stem cells in other cancers and develop new therapies to destroy them.

"What we are working on now is finding out what makes these tumor stem cells different from the other cells in a tumor," Wicha says. "Now that we can actually identify them, we can start developing treatments to specifically target and hopefully eliminate them."

"This is not a cure for cancer," Clarke emphasizes. "But it is a very promising lead, which will focus our efforts to try to find a cure for cancer."

In addition to Al-Hajj, Wicha and Clarke, Sean J. Morrison, Ph.D., a Howard Hughes Medical Institute assistant investigator and U-M assistant professor of internal medicine, is a collaborator in the research study.



The U-M study was funded by the National Cancer Institute. The U-M has applied for a patent on the identity and function of tumor stem cells.

Kara Gavin | EurekAlert!
Further information:
http://www.med.umich.edu/1toolbar/whatsnew.htm

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>